Table 4.
Outcomes | Mood/ cognitive |
Sleep disturbance | Appetite/ Weight disturbance |
Pain |
---|---|---|---|---|
At baseline | ||||
QIDS-SR16 | 0.958 | 0.552 | 0.530 | 0.286 |
CGI-S | 0.427 | 0.223 | 0.106 | 0.104 |
EQ-VAS | -0.296 | -0.134 | -0.201 | -0.176 |
EQ-5D | -0.481 | -0.215 | -0.244 | -0.344 |
At 24 weeks | ||||
QIDS-SR16 | 0.919 | 0.744 | 0.547 | 0.559 |
CGI-S | 0.735 | 0.491 | 0.214 | 0.411 |
EQ-VAS | -0.436 | -0.324 | -0.170 | -0.308 |
EQ-5D | -0.654 | -0.484 | -0.264 | -0.557 |
Note: p-value <0.001 for all correlations
Abbreviations: CGI-S, Clinical Global Impressions of Severity; EQ-VAS, EuroQoL-Visual Analogue Scale; EQ-5D, EuroQoL-5 Dimensions; QIDS-SR16, 16-item Quick Inventory of Depressive Symptomatology Self-Report